Invesco Ltd. Atea Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 195,037 shares of AVIR stock, worth $670,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares

195,037

Previous 196,264 0.63%

Holding current value

$670,927

Previous $792,000 18.56%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.31 - $4.04 $4,061 - $4,957	-1,227 Reduced 0.63%	195,037 $645,000
Q1 2024 May 14, 2024	SELL	$3.09 - $4.56 $78,180 - $115,372	-25,301 Reduced 11.42%	196,264 $792,000
Q4 2023 Feb 12, 2024	BUY	$2.8 - $3.35 $26,471 - $31,670	9,454 Added 4.46%	221,565 $675,000
Q3 2023 Nov 13, 2023	BUY	$3.0 - $3.79 $4,743 - $5,991	1,581 Added 0.75%	212,111 $636,000
Q2 2023 Aug 11, 2023	SELL	$3.21 - $5.06 $20,043 - $31,594	-6,244 Reduced 2.88%	210,530 $787,000
Q1 2023 May 12, 2023	BUY	$3.0 - $4.97 $206,535 - $342,159	68,845 Added 46.54%	216,774 $726,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $136,107 - $193,053	31,289 Added 26.83%	147,929 $711,000
Q3 2022 Nov 14, 2022	SELL	$5.49 - $8.79 $24,661 - $39,484	-4,492 Reduced 3.71%	116,640 $664,000
Q2 2022 Aug 15, 2022	BUY	$5.33 - $8.18 $85,887 - $131,812	16,114 Added 15.34%	121,132 $860,000
Q1 2022 May 16, 2022	BUY	$5.5 - $9.19 $394,487 - $659,152	71,725 Added 215.44%	105,018 $758,000
Q4 2021 Feb 14, 2022	SELL	$7.67 - $44.59 $2.18 Million - $12.7 Million	-284,286 Reduced 89.52%	33,293 $297,000
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $6.31 Million - $10.4 Million	295,781 Added 1356.92%	317,579 $11.1 Million
Q2 2021 Aug 17, 2021	BUY	$19.22 - $59.08 $254,780 - $783,164	13,256 Added 155.19%	21,798 $468,000
Q1 2021 May 17, 2021	BUY	$41.42 - $88.44 $353,809 - $755,454	8,542 New	8,542 $527,000

Others Institutions Holding AVIR

# of Institutions

111

Shares Held

51.2M

Call Options Held

71.8K

Put Options Held

318K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $286M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account